Effect of Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis: A Systematic Review and Meta-Analysis
Open Access
- 25 May 2026
- journal article
- review article
- Published by Korean Society of Otorhinolaryngology-Head and Neck Surgery in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
- Vol. 69 (5) , 209-219
Abstract
An exhalation delivery system for fluticasone (EDS-FLU) is designed to deposit drug into sinonasal regions above the inferior turbinate, particularly sinus drainage pathways not reached by standard nasal steroid sprays. We evaluated the efficacy and safety of EDS-FLU for chronic rhinosinusitis (CRS). We reviewed four independent randomized controlled trials derived from three published articles identified through searches of PubMed, Embase, SCOPUS, Google Scholar, Web of Science, and the Cochrane Library up to April 2024. Outcomes included 22-item Sinonasal Outcome Test (SNOT-22) scores, nasal symptom scores, nasal polyp scores, patient global impression of change (PGIC), responder and surgical indication rates, and adverse events. Compared with EDS-placebo, EDS-FLU produced greater reductions in nasal polyp scores and SNOT-22 scores over 6 months. At 3 months, nasal congestion, facial pain, rhinorrhea, and olfactory dysfunction improved more with EDS-FLU, and PGIC responder and complete response rates were higher at 3 and 6 months. EDS-FLU reduced surgical indication and increased overall responder rates at 3 months but not at 6 months. Epistaxis and nasal septal erosion or ulceration occurred more frequently with EDS-FLU, whereas rates of headache, nasal congestion, nasopharyngitis, and upper respiratory infection were similar between groups. EDS-FLU provides clinically meaningful improvements in subjective and objective outcomes in CRS but is associated with an increased risk of local nasal adverse events, warranting individualized risk-benefit assessment.Keywords
This publication has 31 references indexed in Scilit:
- Yardstick for the medical management of chronic rhinosinusitisAnnals of Allergy, Asthma & Immunology, 2022
- Magnetic resonance imaging evaluation of the distribution of spray and irrigation devices within the sinonasal cavitiesInternational Forum of Allergy & Rhinology, 2019
- EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2018
- Intranasal steroids versus placebo or no intervention for chronic rhinosinusitisCochrane Database of Systematic Reviews, 2016
- Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness studyInternational Forum of Allergy & Rhinology, 2016
- International Consensus Statement on Allergy and Rhinology: Rhinosinusitis Executive SummaryInternational Forum of Allergy & Rhinology, 2016
- The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current HypothesesCurrent Allergy and Asthma Reports, 2015
- The fate of chronic rhinosinusitis sufferers after maximal medical therapyInternational Forum of Allergy & Rhinology, 2014
- Nasal drug delivery devices: characteristics and performance in a clinical perspective—a reviewDrug Delivery and Translational Research, 2012
- A Randomized Controlled Trial of Mometasone Furoate Nasal Spray for the Treatment of Nasal PolyposisJAMA Otolaryngology–Head & Neck Surgery, 2006